Skip to main content
Figure 4 | Breast Cancer Research

Figure 4

From: Increased cell survival by inhibition of BRCA1 using an antisense approach in an estrogen responsive ovarian carcinoma cell line

Figure 4

Estrogen dependent BG-1 cells infected with BRCA1 antisense continue to proliferate in the absence of estrogen. (A) BG-1 NEO control subclone on day 14 of estrogen deprivation. (B) BG-1 NEO at day 9 of 10-8 mol/l estrogen treatment. (C) BG-1 BRCA1 antisense AS-4 subclone on day 14 of estrogen deprivation. (D) BG-1 BRCA1 antisense infected cells at day 9 of 10-8 mol/l estrogen treatment.

Back to article page